Single‐cell analysis of tumor microenvironment and cell adhesion reveals that interleukin‐1 beta promotes cancer cell proliferation in breast cancer
Authors:
Open Access
- 11 June 2024
- journal article
- research article
- Published by Wiley in Animal Models and Experimental Medicine
- Vol. 7 (5) , 617-625
Abstract
Background: Triple‐negative breast cancer (TNBC), which is so called because of the lack of estrogen receptors (ER), progesterone receptors (PR), and human epidermal growth factor receptor 2 (HER2) receptors on the cancer cells, accounts for 10%–15% of all breast cancers. The heterogeneity of the tumor microenvironment is high. However, the role of plasma cells controlling the tumor migration progression in TNBC is still not fully understood.Methods: We analyzed single‐cell RNA sequencing data from five HER2 positive, 12 ER positive/PR positive, and nine TNBC samples. The potential targets were validated by immunohistochemistry.Results: Plasma cells were enriched in TNBC samples, which was consistent with validation using data from The Cancer Genome Atlas. Cell communication analysis revealed that plasma cells interact with T cells through the intercellular adhesion molecule 2–integrin–aLb2 complex, and then release interleukin 1 beta (IL1B), as verified by immunohistochemistry, ultimately promoting tumor growth.Conclusion: Our results revealed the role of plasma cells in TNBC and identified IL1B as a new prognostic marker for TNBC.Keywords
This publication has 28 references indexed in Scilit:
- Single‐cell RNA sequencing technologies and applications: A brief overviewClinical and Translational Medicine, 2022
- IL-1β in breast cancer bone metastasisExpert Reviews in Molecular Medicine, 2022
- Understanding cell‐cell communication and signaling in the colorectal cancer microenvironmentClinical and Translational Medicine, 2021
- Breast Cancer TreatmentJAMA, 2019
- Single-cell RNA sequencing to explore immune cell heterogeneityNature Reviews Immunology, 2017
- Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancerNature Communications, 2017
- Breast cancerThe Lancet, 2017
- Clonal Heterogeneity and Tumor Evolution: Past, Present, and the FutureCell, 2017
- An overview of triple-negative breast cancerArchives of Gynecology and Obstetrics, 2015
- Expression of interleukin-1? in human breast carcinomaCancer, 1997